These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 32339553)

  • 21. Oxidative, inflammatory, genetic, and epigenetic biomarkers associated with chronic obstructive pulmonary disorder.
    Aggarwal T; Wadhwa R; Thapliyal N; Sharma K; Rani V; Maurya PK
    J Cell Physiol; 2019 Mar; 234(3):2067-2082. PubMed ID: 30171697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Searching for biomarkers of chronic obstructive pulmonary disease using proteomics: The current state.
    Cagnone M; Salvini R; Bardoni A; Fumagalli M; Iadarola P; Viglio S
    Electrophoresis; 2019 Jan; 40(1):151-164. PubMed ID: 30216498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel biomarkers for cardiovascular risk assessment: current status and future directions.
    MacNamara J; Eapen DJ; Quyyumi A; Sperling L
    Future Cardiol; 2015 Sep; 11(5):597-613. PubMed ID: 26491788
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coexisting chronic obstructive pulmonary disease and cardiovascular disease in clinical practice: a diagnostic and therapeutic challenge.
    Leong P; Macdonald MI; Ko BS; Bardin PG
    Med J Aust; 2019 May; 210(9):417-423. PubMed ID: 30907000
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Procalcitonin Biomarker Algorithm Reduces Antibiotic Prescriptions, Duration of Therapy, and Costs in Chronic Obstructive Pulmonary Disease: A Comparison in the Netherlands, Germany, and the United Kingdom.
    van der Maas ME; Mantjes G; Steuten LM
    OMICS; 2017 Apr; 21(4):232-243. PubMed ID: 28388301
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systems Biology Research into Cardiovascular Disease: Contributions of Lipidomics-based Approaches to Biomarker Discovery.
    De Leon H; Boue S; Szostak J; Peitsch MC; Hoeng J
    Curr Drug Discov Technol; 2015; 12(3):129-54. PubMed ID: 26135855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transcriptomics, proteomics and metabolomics driven biomarker discovery in COPD: an update.
    Ghosh N; Dutta M; Singh B; Banerjee R; Bhattacharyya P; Chaudhury K
    Expert Rev Mol Diagn; 2016 Aug; 16(8):897-913. PubMed ID: 27267972
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current Controversies in the Pharmacological Treatment of Chronic Obstructive Pulmonary Disease.
    Singh D; Roche N; Halpin D; Agusti A; Wedzicha JA; Martinez FJ
    Am J Respir Crit Care Med; 2016 Sep; 194(5):541-9. PubMed ID: 27585383
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lipidomic methodologies for biomarkers of chronic inflammation in nutritional research: ω-3 and ω-6 lipid mediators.
    Dasilva G; Medina I
    Free Radic Biol Med; 2019 Nov; 144():90-109. PubMed ID: 30902758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Should we treat chronic obstructive pulmonary disease as a cardiovascular disease?
    Rabinovich RA; MacNee W
    Expert Rev Respir Med; 2015 Aug; 9(4):459-72. PubMed ID: 26190174
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of MMP-9 as a biomarker for detecting progression of chronic obstructive pulmonary disease.
    Abd El-Fatah MF; Ghazy MA; Mostafa MS; El-Attar MM; Osman A
    Biochem Cell Biol; 2015 Dec; 93(6):541-7. PubMed ID: 26291981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipidomics applications for disease biomarker discovery in mammal models.
    Zhao YY; Cheng XL; Lin RC; Wei F
    Biomark Med; 2015; 9(2):153-68. PubMed ID: 25689902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers determining cardiovascular risk in patients with kidney disease.
    Siasos G; Tousoulis D; Michalea S; Oikonomou E; Kolia C; Kioufis S; Synetos A; Vlasis K; Papavassiliou AG; Stefanadis C
    Curr Med Chem; 2012; 19(16):2555-71. PubMed ID: 22489717
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular Biomarkers in Asthma and COPD.
    Bakakos P; Patentalakis G; Papi A
    Curr Top Med Chem; 2016; 16(14):1599-609. PubMed ID: 26420364
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miRNAS in cardiovascular diseases: potential biomarkers, therapeutic targets and challenges.
    Zhou SS; Jin JP; Wang JQ; Zhang ZG; Freedman JH; Zheng Y; Cai L
    Acta Pharmacol Sin; 2018 Jul; 39(7):1073-1084. PubMed ID: 29877320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Flavonoids and Reduction of Cardiovascular Disease (CVD) in Chronic Obstructive Pulmonary Disease (COPD).
    Russo P; Prinzi G; Lamonaca P; Cardaci V; Fini M
    Curr Med Chem; 2019; 26(39):7048-7058. PubMed ID: 29756566
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk assessment in asthma and COPD: a potential role for biomarkers?
    Taylor DR
    Thorax; 2009 Mar; 64(3):261-4. PubMed ID: 19252021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The matrikine PGP as a potential biomarker in COPD.
    Abdul Roda M; Fernstrand AM; Redegeld FA; Blalock JE; Gaggar A; Folkerts G
    Am J Physiol Lung Cell Mol Physiol; 2015 Jun; 308(11):L1095-101. PubMed ID: 26033353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biomarkers obtained by non-invasive methods in patients with COPD: where do we stand, what do we expect?
    Hillas G; Loukides S; Kostikas K; Bakakos P
    Curr Med Chem; 2009; 16(22):2824-38. PubMed ID: 19689266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lipidomics, Biomarkers, and Schizophrenia: A Current Perspective.
    Sethi S; Hayashi MA; Barbosa BS; Pontes JG; Tasic L; Brietzke E
    Adv Exp Med Biol; 2017; 965():265-290. PubMed ID: 28132184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.